Guía de Práctica Clínica sobre Lupus Eritematoso Sistémico

240 Zein N, Ganuza C, Kushner I. Significance of serum C-reactive protein elevation in
patients with systemic lupus erythematosus. Arthritis Rheum 1979; 22: 7–12.
241 Bertsias G, Cervera R, Boumpas D. Systemic lupus erythematosus: pathogenesis and
clinical features. In: BMJ Group (ed). EULAR Textbook of rheumatic diseases. London
(UK), 2012, pp 476–505.
242 Bertsias G, Ioannidis JP a, Boletis J, Bombardieri S, Cervera R, Dostal C et al. EULAR
recommendations for the management of systemic lupus erythematosus. Report of a Task
Force of the EULAR Standing Committee for International Clinical Studies Including
Therapeutics. Ann Rheum Dis 2008; 67: 195–205.
243 Mosca M, Tani C, Aringer M, Bombardieri S, Boumpas D, Brey R et al. European League
Against Rheumatism recommendations for monitoring patients with systemic lupus
erythematosus in clinical practice and in observational studies. Ann Rheum Dis 2011; 69:
1269–1274.
244 Bertsias GK, Ioannidis JP a, Aringer M, Bollen E, Bombardieri S, Bruce IN et al. EULAR
recommendations for the management of systemic lupus erythematosus with
neuropsychiatric manifestations: report of a task force of the EULAR standing committee
for clinical affairs. Ann Rheum Dis 2010; 69: 2074–2082.
245 Nikpour M, Gladman DD, Ibanez D, Harvey PJ, Urowitz MB. Variability over time and
correlates of cholesterol and blood pressure in systemic lupus erythematosus : a
longitudinal cohort study. Arthritis Res Ther 2010; 12: 1–9.
246 Wajed J, Ahmad Y, Durrington PN, Bruce IN. Prevention of cardiovascular disease in
systemic lupus erythematosus--proposed guidelines for risk factor management.
Rheumatology 2004; 43: 7–12.
247 Gladman DD, Ibañez D, Ruiz I, Urowitz MB. Recommendations for frequency of visits to
monitor systemic lupus erythematosus in asymptomatic patients: data from an
observational cohort study. J Rheumatol 2013; 40: 630–633.
248 Gladman DD, Urowitz MB, Rahman P, Ibañez D, Tam L-S. Accrual of organ damage
over time in patients with systemic lupus erythematosus. J Rheumatol 2003; 30: 1955–9.
249 Walz L, Gladman D, Urowitz M. Serologically active clinically quiescent systemic lupus
erythematosus--predictors of clinical flares. J Rheumatol 1994; 21: 2239–2241.
250 Steiman AJ, Gladman DD, Ibañez D, Urowitz MB. Prolonged serologically active
clinically quiescent systemic lupus erythematosus: frequency and outcome. J Rheumatol
2010; 37: 1822–1827.
251 American College of Rheumatology Ad Hoc Committee on systemic Lupus
Erythematosus Guidelines. Guidelines for referral and management of systemic lupus
erythematosus in adults. Arthritis Rheum 1999; 42: 1785–1795.
252 Gladman DD, Hirani N, Ibañez D, Urowitz MB. Clinically Active Serologically Quiescent
Systemic Lupus Erythematosus. J Rheumatol 2003; 30: 1960–1962.
GUÍA DE PRÁCTICA CLÍNICA SOBRE LUPUS ERITEMATOSO SISTÉMICO 453